Jump to content

Daniel O. Griffin: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
publication list
Line 46: Line 46:
== References ==
== References ==
{{reflist}}
{{reflist}}

[[Category:Living people]]

Revision as of 12:39, 4 February 2021

Dr. Daniel O. Griffin, is a physician-scientist, research scholar in Infectious Diseases and Immunology.[1][2][3]

Education

Dr. Griffin attended the New York University School of Medicine and then completed his 3-year categorical internal medicine residency at the University of Utah.[4] He obtained a certification in the Business of Medicine from John Hopkins Carey Business School, Baltimore MD.[5]

He earned the Ph.D. in Molecular Medicine from the Elmezzi Graduate School of Molecular Medicine, Manhasset, NY in the year 2012, along with research work in the identification of phenotype of the human B1 cell.[6]

In 2014, he completed a Fellowship in Infectious Ddiseases from North Shore-Long Island Jewish Health System-Hofstra University, Manhasset, NY.[7] He has been at Columbia University since 2014.

Research and career

Dr. Griffin’s work includes investigating the potential role of human B1 cells and natural antibodies in the development of HIV-associated malignancies.[8] He has a special focus on HIV and Tropical Medicine.[9] His research interests are broad and include studies on Infectious Disease and Immunology, Molecular medicine & Tropical Medicine and many others.

His current research focuses on HIV-1 and stem cell latency, as well as stem cell gene therapy utilizing retroviral vectors and COVID-19.[10][11]

Awards

During his career, Dr. Griffin has been the recipient of the following awards and honors:

  • Ruth and Leonard Litwin Fellowship Award in 2011.[12]
  • Davies Award in 2006 (An international award given by HIMSS, the largest health IT organization in the world).[13]

Dr. Griffin is also an active member in the following scientific societies or associations:

Patents

  • Human b1 cells and uses thereof.[15]

Publications

Dr. Griffin is the author of numerous research papers with more than 20 publications in several international scientific journals; the following list names a few of them:

  • Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−[16]
  • Identifying Optimal COVID- 19 Testing Strategies for School and Businesses: Balancing testing frequency, individual test technology, and cost.[17]
  • Human B-1 cells take the stage.[18]
  • A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus.[19]
  • Human “orchestrator” CD11b+ B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity.[20]
  • Human b1 cell frequency: isolation and analysis of human b1 cells.[21]
  • Human B1 cells are CD3−: A reply to “A human equivalent of mouse B-1 cells?” and “The nature of circulating CD27+CD43+ B cells”.[22]

Google Scholar - Daniel O'Connell Griffin

References

  1. ^ "parasiteswithoutborders".{{cite web}}: CS1 maint: url-status (link)
  2. ^ "Daniel Griffin, MD, PhD | Northwell Health". www.northwell.edu. Retrieved 2021-02-04.
  3. ^ "FIMRC — Do No Harm But Lots Of Good!". FIMRC. Retrieved 2021-02-04.
  4. ^ "Daniel Griffin, MD, PhD | Northwell Health". www.northwell.edu. Retrieved 2021-02-04.
  5. ^ "parasiteswithoutborders".{{cite web}}: CS1 maint: url-status (link)
  6. ^ Griffin, Daniel O.; Holodick, Nichol E.; Rothstein, Thomas L. (2011-01-17). "Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-". The Journal of Experimental Medicine. 208 (1): 67–80. doi:10.1084/jem.20101499. ISSN 1540-9538. PMC 3023138. PMID 21220451.
  7. ^ "Dr. Daniel Griffin, MD – Lake Success, NY | Infectious Disease on Doximity". Doximity. Retrieved 2021-02-04.
  8. ^ Rothstein, Thomas L.; Griffin, Daniel O.; Holodick, Nichol E.; Quach, Tam D.; Kaku, Hiroaki (2013-05). "Human B-1 cells take the stage". Annals of the New York Academy of Sciences. 1285: 97–114. doi:10.1111/nyas.12137. ISSN 1749-6632. PMC 4429725. PMID 23692567. {{cite journal}}: Check date values in: |date= (help)
  9. ^ "Bio". www.diabetestechnology.org. Retrieved 2021-02-04.
  10. ^ Ngo, Binh T.; Marik, Paul; Kory, Pierre; Shapiro, Leland; Thomadsen, Raphael; Iglesias, Jose; Ditmore, Stephen; Rendell, Marc; Varon, Joseph; Dubé, Michael; Nanda, Neha (2021-01-23). "THE TIME TO OFFER TREATMENTS FOR COVID-19". medRxiv: 2020.05.27.20115238. doi:10.1101/2020.05.27.20115238.
  11. ^ Griffin, Daniel O.; Rothstein, Thomas L. (2012). "Human b1 cell frequency: isolation and analysis of human b1 cells". Frontiers in Immunology. 3: 122. doi:10.3389/fimmu.2012.00122. ISSN 1664-3224. PMC 3360193. PMID 22654880.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  12. ^ "Northwell Health Foundation". support.northwell.edu. Retrieved 2021-02-04.
  13. ^ "Daniel Griffin, MD, HIMSS 2006 Davies award for excellence in Electronic Medical Records | EMR Software | Praxis EMR, EHR Software". www.praxisemr.com. Retrieved 2021-02-04.
  14. ^ "Daniel Griffin, M.D., Ph.D." ASM.org. Retrieved 2021-02-04.
  15. ^ [1], "Human b1 cells and uses thereof", issued 2011-09-22 
  16. ^ Griffin, Daniel O.; Holodick, Nichol E.; Rothstein, Thomas L. (2011-01-17). "Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−". Journal of Experimental Medicine. 208 (1): 67–80. doi:10.1084/jem.20101499. ISSN 0022-1007. PMC 3023138. PMID 21220451.{{cite journal}}: CS1 maint: PMC format (link)
  17. ^ Lyng, Gregory D.; Sheils, Natalie E.; Kennedy, Caleb J.; Griffin, Daniel; Berke, Ethan M. (2020-10-12). "Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost". medRxiv: 2020.10.11.20211011. doi:10.1101/2020.10.11.20211011.
  18. ^ Rothstein, Thomas L.; Griffin, Daniel O.; Holodick, Nichol E.; Quach, Tam D.; Kaku, Hiroaki (2013-05). "Human B-1 cells take the stage". Annals of the New York Academy of Sciences. 1285: 97–114. doi:10.1111/nyas.12137. ISSN 1749-6632. PMC 4429725. PMID 23692567. {{cite journal}}: Check date values in: |date= (help)
  19. ^ Griffin, Daniel O.; Rothstein, Thomas L. (2011-12-19). "A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus". Journal of Experimental Medicine. 208 (13): 2591–2598. doi:10.1084/jem.20110978. ISSN 0022-1007. PMC 3244038. PMID 22110167.{{cite journal}}: CS1 maint: PMC format (link)
  20. ^ Griffin, Daniel O.; Rothstein, Thomas L. (2012/06). "Human "Orchestrator" CD11b + B1 Cells Spontaneously Secrete Interleukin-10 and Regulate T-Cell Activity". Molecular Medicine. 18 (6): 1003–1008. doi:10.2119/molmed.2012.00203. ISSN 1528-3658. PMC 3459484. PMID 22634719. {{cite journal}}: Check date values in: |date= (help)CS1 maint: PMC format (link)
  21. ^ Griffin, Daniel; Rothstein, Thomas L. (2012). "Human B1 Cell Frequency: Isolation and Analysis of Human B1 Cells". Frontiers in Immunology. 3. doi:10.3389/fimmu.2012.00122. ISSN 1664-3224. PMC 3360193. PMID 22654880.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  22. ^ Griffin, Daniel O.; Holodick, Nichol E.; Rothstein, Thomas L. (2011-12-19). "Human B1 cells are CD3−: A reply to "A human equivalent of mouse B-1 cells?" and "The nature of circulating CD27+CD43+ B cells"". Journal of Experimental Medicine. 208 (13): 2566–2569. doi:10.1084/jem.20111761. ISSN 0022-1007. PMC 3244032. PMID 22184682.{{cite journal}}: CS1 maint: PMC format (link)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Daniel_O._Griffin&oldid=1004795938"